Tekla Health Care Investors Co (HQH) closed at $20.20 on October 20, 2026, up 4.1% from the previous close, on volume of 211,583 shares (30-day average 175,863).
Data as of October 20, 2026.
No headlines found.
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
PRNewswire (Wed, 30-Sep 4:17 PM ET)
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
PRNewswire (Tue, 11-Aug 4:17 PM ET)
The Fund's investment objective is long-term capital appreciation through investment in companies in the healthcare industry. This is a broad mandate and the Fund invests primarily in securities of public and private companies that are believed by the Fund's Investment Adviser, Tekla Capital Management LLC (the Adviser) to have significant potential for above-average growth. Effective October 15, 2014, the name of the Fund changed from H&Q Healthcare Investors to Tekla Healthcare Investors. HQH primarily invests in the healthcare industry (including biotechnology, medical devices, and pharmaceuticals). The Fund's objective is to provide long-term capital appreciation through investments in companies in the healthcare industry believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. Management believes this provides a unique opportunity not usually available to mutual fund investors.
Tekla Health Care Investors Co trades on the NYSE stock market under the symbol HQH.
As of October 20, 2026, HQH stock price climbed to $20.20 with 211,583 million shares trading.
HQH has a beta of 1.03, meaning it tends to be more sensitive to market movements. HQH has a correlation of 0.23 to the broad based SPY ETF.
HQH has a market cap of $1.19 billion. This is considered a Small Cap stock.
In the last 3 years, HQH traded as high as $24.85 and as low as $13.77.
HQH has outperformed the market in the last year with a price return of +18.1% while the SPY ETF gained +15.7%. However, in the short term, HQH had mixed performance relative to the market. It has underperformed in the last 3 months, returning -0.2% vs +3.9% return in SPY. But in the last 2 weeks, HQH shares have fared better than the market returning +4.5% compared to SPY -1.3%.
HQH support price is $18.97 and resistance is $19.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HQH shares will trade within this expected range on the day.
